Elderly patients with breast cancer experience significantly worse survival when they receive less than standard systemic treatment, or have second primary disease other than breast cancer in their follow-up period.
Age is one of the most significant risk factors for breast cancer and, although proportional incidence is uncertain, the absolute number of elderly patients is increasing. The aim of the study conducted by Moon et al. was to outline breast cancer in elderly (Korean) patients and examine survival by clinicopathologic factors such as age, stage, and disease subtype . A total of 1,103 patients who were diagnosed with and completed their primary treatment for breast cancer between 2000 and 2013 were included. Clinicopathologic data was collected with retrospective data review. Survival data and risk factors - if the survival was statistically significant - were obtained. Mean age of the patients was 52.71 years (range 22-89) and subjects were divided in...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Sensory peripheral neuropathy after taxane treatment is not uncommon Next Article
Better outcomes with oral paclitaxel than intravenous paclitaxel in metastatic breast cancer »
Table of Contents: SABCS 2019
Screening, Detection, and Diagnosis
Phase 2 Trial Update
Phase 3 Trial Update
Long-Term Study Results
Triple-Negative Breast Cancer
HER2-Positive Breast Cancer
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.